Table 1 Baseline characteristics of patients included in the study
Characteristics | Total |
|---|---|
N | 290 |
Age (mean±SD) | 54.9±12.1 |
Male gender | 124 (42.8%) |
Ethnicity/color | |
White | 226 (77.9%) |
Pardo | 43 (14.8%) |
Black | 21 (7.2%) |
Alcohol > 20 g/day | 55(19.3%) |
BMI (mean±SD) | 27.1±6.1 |
Glucose (mean±SD) | 93.1±49.4 |
Insulin (mean±SD) | 15.2±32.2 |
ALT (mean±SD) | 62.3±49.4 |
AST (mean±SD) | 49.8±38.1 |
Total cholesterol (mean±SD) | 173.9±39.8 |
LDL-C (mean±SD) | 95.5±32.8 |
HDL-C (mean±SD) | 55.3±18.5 |
VLDL-C (mean±SD) | 23.9±20.9 |
Triglycerides (mean±SD) | 109.3±66.8 |
Hepatic steatosis ≥ 5% | 143 (49.3%) |
Liver fibrosis (Metavir ≥ F3) | 58 (20%) |
HCV genotype 3 | 45 (15.7%) |
PNPLA3 rs738409 | |
CC | 133 (45.9%) |
CG | 63 (21.7%) |
GG | 94 (32.4%) |
TM6F2 rs58542926 | |
CC | 261 (90%) |
CT | 29 (10%) |